Cochlear (COH) slumps to 4-year low amid U.S. government probe into relationships with doctors. Goldman Sachs JBWere cuts long-term
rating to Hold from Buy; says implications of probe include costs and risk to U.S. sales growth. Cites ongoing uncertainty, but GS sees downside floor price
of A$16.
There uou go. Like there comment weeks ago about LHG when LHG falls from $1.20 to $1.05.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$313.29 |
Change
1.350(0.43%) |
Mkt cap ! $20.48B | |||
| Open | High | Low | Value | Volume |
| $312.00 | $313.73 | $309.83 | $70.45M | 225.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16 | $312.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $313.37 | 36 | 1 |
View Market Depth
| Last trade - 16.15pm 13/08/2025 (20 minute delay) ? |
| COH (ASX) Chart |